Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Jiangsu Hengrui Medicine Co., Ltd.    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO., LTD.

(600276)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
87.3 86.91 86.12 87.17 86.13 Last
18016860 17163430 32883840 23837750 20023750 Volume
+0.80% -0.45% -0.91% +1.22% -1.19% Change
Financials
Sales 2020 28 768 M 4 375 M 4 375 M
Net income 2020 6 450 M 981 M 981 M
Net cash position 2020 14 084 M 2 142 M 2 142 M
P/E ratio 2020 70,2x
Yield 2020 0,24%
Sales 2021 36 126 M 5 495 M 5 495 M
Net income 2021 8 260 M 1 256 M 1 256 M
Net cash position 2021 18 322 M 2 787 M 2 787 M
P/E ratio 2021 54,0x
Yield 2021 0,30%
Capitalization 455 B 69 214 M 69 219 M
EV / Sales 2020 15,3x
EV / Sales 2021 12,1x
Nbr of Employees 24 431
Free-Float 38,7%
More Financials
Company
Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products: - anti-tumor drugs (No. 1 Chinese); - Anesthetic drugs; - contrast agents: used in medical imaging; - anti-inflammatory drugs; - drugs for the treatment of cardiovascular diseases. 
More about the company
Notations Surperformance© of Jiangsu Hengrui Medicine Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about JIANGSU HENGRUI MEDICINE CO., LTD.
10/19JIANGSU HENGRUI MEDICINE : Nine-Month Net Profit Rose 14%
DJ
10/15JIANGSU HENGRUI MEDICINE CO., LTD. : quaterly earnings release
08/21Stymied at home, Korea's mom and pop investors charge into China tech stocks
RE
08/21Stymied at home, Korea's mom and pop investors charge into China tech stocks
RE
08/18THERMO FISHER SCIENTIFIC : Signs Companion Diagnostic Agreement with Hengrui The..
AQ
05/25JIANGSU HENGRUI MEDICINE CO., LTD. : 20% Stock Dividend
FA
05/25JIANGSU HENGRUI MEDICINE CO., LTD. : Ex-dividend day for final dividend
FA
04/23JIANGSU HENGRUI MEDICINE CO., LTD. : quaterly earnings release
03/18JIANGSU HENGRUI MEDICINE CO., LTD. : annual earnings release
01/21How a virus impacts the economy and markets
RE
2019JIANGSU HENGRUI MEDICINE : Mycovia Pharmaceuticals and Jiangsu Hengrui Medicine ..
BU
2019JIANGSU HENGRUI MEDICINE CO. : Ex-dividend day for final dividend
FA
2019JIANGSU HENGRUI MEDICINE CO. : 20% Stock Dividend
FA
2018JIANGSU HENGRUI MEDICINE CO LTD : Ex-dividend day for final dividend
FA
2018JIANGSU HENGRUI MEDICINE CO LTD : BONUS ISSUE: 3 new shares for 10 existing shar..
FA
More news
News in other languages on JIANGSU HENGRUI MEDICINE CO., LTD.
10/15JIANGSU HENGRUI MEDICINE CO., LTD. : Veröffentlichung des Quartalsergebnisses
10/15JIANGSU HENGRUI MEDICINE CO., LTD. : publication des résultats trimestriels
04/23JIANGSU HENGRUI MEDICINE CO., LTD. : publication des résultats trimestriels
04/23JIANGSU HENGRUI MEDICINE CO., LTD. : Veröffentlichung des Quartalsergebnisses
04/06VALEURS MOYENNES DU BTP : Après l'arrêt total, la reprise des chantiers reste co..
More news
Chart JIANGSU HENGRUI MEDICINE CO., LTD.
Duration : Period :
Jiangsu Hengrui Medicine Co., Ltd. Technical Analysis Chart | 600276 | CNE0000014W7 | MarketScreener
Technical analysis trends JIANGSU HENGRUI MEDICINE CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 101,33 CNY
Last Close Price 86,13 CNY
Spread / Highest target 32,4%
Spread / Average Target 17,7%
Spread / Lowest Target -13,9%
EPS Revisions
Managers
NameTitle
Yun Shu Zhou Chairman & General Manager
Wei Dong Chairman-Supervisory Board
Song Zhou Chief Financial Officer
Xin Hua Jiang Vice Chairman
Jie Ping Sun Director & Deputy General Manager
Sector and Competitors
1st jan.Capitalization (M$)
JIANGSU HENGRUI MEDICINE CO., LTD.18.09%69 882
JOHNSON & JOHNSON-1.37%378 744
ROCHE HOLDING AG-4.28%281 946
PFIZER INC.-6.59%203 437
MERCK & CO., INC.-11.89%202 757
NOVARTIS AG-12.66%200 273